Elly De La Cruz has 3 RBIs, scores 3 runs as Reds rally to beat Tigers 8-4

DETROIT (AP) — Elly De La Cruz homered, scored three times and drove in three runs as the Cincinnati Reds rallied to beat the Detroit Tigers 8-4 on Sunday.

De La Cruz singled and scored in the fourth, had an RBI single before scoring in a four-run eighth and hit a two-run homer in the ninth. He has homered in a career-best four straight games.

Three Tigers’ errors led to five unearned runs. With the Tigers leading 4-2, TJ Friedl led off the eighth with a grounder to the mound, but Brant Hurter misplayed it into a two-base error.

Tigers closer Will Vest (5-1) came in, but Matt McLain singled, putting runners on the corners, and De La Cruz followed with an RBI single.

A failed double-play attempt left the bases loaded, and Will Benson tied the game with a sacrifice fly.

Gavin Lux followed with an RBI single and the fourth run scored on a wild pitch. Vest left the game after the play with a possible injury.

The Tigers took a 1-0 lead in the third on Jahmai Jones' home run, but the Reds scored twice in the fourth.

De La Cruz led off with a single and took second on a throwing error by Sawyer Gipson-Long. He scored on a single by Tyler Stephenson, and an error by Javier Báez led to a sacrifice fly by Connor Joe.

The Reds had runners in scoring position with one out in the fifth and seventh innings, but McLain and Spencer Steer hit into inning-ending double plays.

De La Cruz hit .462 with four homers, six RBIs and eight runs scored on Cincinnati's 4-2 road trip.

Both teams start three-game series on Tuesday. Detroit remains home to face the Pittsburgh Pirates, with RHP Casey Mize (6-2, 2.95) scheduled for the opener against Pirates LHP Bailey Falter (5-3, 3.36). The Reds return home to face the Minnesota Twins. LHP Andrew Abbott (6-1, 1.87) will start for Cincinnati on Tuesday against RHP David Festa (1-1, 4.76).

AP MLB: https://apnews.com/hub/mlb

Cincinnati Reds' Christian Encarnacion-Strand scores on a Detroit Tigers pitcher Will Vest wild pitch in the eighth inning during a baseball game, Sunday, June 15, 2025, in Detroit. (AP Photo/Paul Sancya)

Detroit Tigers' Javier Báez runs out a double against the Cincinnati Reds in the seventh inning during a baseball game, Sunday, June 15, 2025, in Detroit. (AP Photo/Paul Sancya)

Cincinnati Reds' Gavin Lux hits a one-run single against the Detroit Tigers in the eighth inning during a baseball game, Sunday, June 15, 2025, in Detroit. (AP Photo/Paul Sancya)

Cincinnati Reds' Elly De La Cruz points to the dugout after hitting a one-run single against the Detroit Tigers in the eighth inning during a baseball game, Sunday, June 15, 2025, in Detroit. (AP Photo/Paul Sancya)

CUYAHOGA FALLS, Ohio--(BUSINESS WIRE)--Jan 13, 2026--

As medical device manufacturers face mounting pressures to reduce environmental risk, improve traceability, and accelerate product development, Americhem is preparing to highlight a suite of new technologies that reflect these industry shifts at Pharmapack (Paris) and MD&M West (Anaheim) in early 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112893294/en/

The company, known for its healthcare-focused polymer compounds and masterbatches, will showcase five key technologies, each designed to respond to the technical and regulatory complexities facing modern medtech—particularly in areas like connected care, self-administered delivery, and robotic-assisted interventions. Among the engineered solutions:

Americhem is actively engaging with OEM partners to co-develop and validate them for next-generation device applications. The company reports continued double-digit growth in its healthcare segment, supported by its ISO 13485-certified facilities in the U.S. and Denmark and upcoming expansion into China in 2026.

Americhem will also participate in the SPE Minitec Conference held during MD&M West, joining technical discussions on materials innovation for evolving care models.

“There’s a clear shift happening—material choices are now deeply tied to sustainability goals, regulatory scrutiny, and device functionality,” said Matt Miklos, Vice President of Corporate Strategy and M&A at Americhem. “What we’re bringing to these shows is not a catalog—it’s a pipeline of engineered solutions designed to be customized, scaled, and validated in partnership with OEMs who are navigating that complexity every day.”

Americhem’s approach emphasizes long-term material consistency, global compliance, and early design collaboration—factors increasingly prioritized by engineering and R&D teams charged with building the next wave of medical devices.

For technical inquiries or to request early access to sample materials, visit www.americhem.com/industries/healthcare/.

About Americhem

Americhem is an innovative, technology-driven leader in the global polymer industry. Its foundation is built around delivering Performance, Solutions and Trust through close collaboration with customers. All of the company's products are backed by complete technical support that ensures quality, reliability, and value. Americhem operates 10 manufacturing plants and maintains sales offices throughout the world. Visit www.Americhem.com for more information.

Engineered for medical nonwovens, Americhem’s PFAS-free nDryve™ additive delivers fluorine-free fluid repellency to surgical gowns, hygiene drapes, and barrier fabrics—addressing OEM demand for safer, sustainable performance in single-use healthcare textiles.

Americhem’s laser-marking ready thermoplastics enable permanent, high-contrast part identification directly on molded medical components—ideal for cleanroom environments where labels or inks are not viable. Designed for compliance and traceability, these materials support regulatory and workflow demands in modern device manufacturing.